Osteoporosis
Osteoporosis is a condition characterized by weak and brittle bones, making them more susceptible to fractures. It often develops silently over many years, leading to an increased risk of breaks, especially in the hip, spine, and wrist.
Bone Health: Alendronate Discontinuation Study
We are investigating the effects of stopping alendronate on fracture risk in patients with osteoporosis. The study also looks at whether specific health factors can predict bone loss after discontinuation.
>2 yearsMonitoring phase (IV)No PlaceboCost ReimbursementStandard MedicinesOralInternal MedicineOtolaryngology
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you a postmenopausal woman?
- Have you been treated with Alendronate for more than 3 years without a major osteoporotic fracture?
- Have you had a major osteoporotic fracture more than 3 years ago after being treated with Alendronate for more than 5 years?
- Have you ever had an atypical femur fracture?
- Do you have uncontrolled inflammatory disease or active cancer?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Aalborg University Hospital
endocrinology
Aalborg, Denmark
Bispebjerg Hospital
endocrinology
Copenhagen, Denmark
Esbjerg Og Grindsted Sygehus
Endocrinology
Esbjerg, Denmark
Sponsor: Odense University Hospital
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.